Found: 23
Select item for more details and to access through your institution.
Translating genetic association of lipid levels for biological and clinical application.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 617, doi. 10.1007/s10557-021-07156-4
- By:
- Publication type:
- Article
The Impairment in Kidney Function in the Oral Anticoagulation Era. A Pathophysiological Insight.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 505, doi. 10.1007/s10557-020-07004-x
- By:
- Publication type:
- Article
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 575, doi. 10.1007/s10557-020-07063-0
- By:
- Publication type:
- Article
Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 411, doi. 10.1007/s10557-020-07073-y
- By:
- Publication type:
- Article
Concepts and Controversies: Lipid Management in Patients with Chronic Kidney Disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 479, doi. 10.1007/s10557-020-07020-x
- By:
- Publication type:
- Article
Translating Cardiovascular Genomics to Clinical Practice.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 637, doi. 10.1007/s10557-021-07175-1
- By:
- Publication type:
- Article
Genetics of Triglyceride-Rich Lipoproteins Guide Identification of Pharmacotherapy for Cardiovascular Risk Reduction.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 677, doi. 10.1007/s10557-021-07168-0
- By:
- Publication type:
- Article
Targeting Human lncRNAs for Treating Cardiometabolic Diseases.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 655, doi. 10.1007/s10557-021-07158-2
- By:
- Publication type:
- Article
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 521, doi. 10.1007/s10557-020-07010-z
- By:
- Publication type:
- Article
The Interface of Therapeutics and Genomics in Cardiovascular Medicine.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 663, doi. 10.1007/s10557-021-07149-3
- By:
- Publication type:
- Article
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 627, doi. 10.1007/s10557-020-07105-7
- By:
- Publication type:
- Article
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 427, doi. 10.1007/s10557-020-07070-1
- By:
- Publication type:
- Article
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 533, doi. 10.1007/s10557-020-07061-2
- By:
- Publication type:
- Article
Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 587, doi. 10.1007/s10557-020-07002-z
- By:
- Publication type:
- Article
Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the "Prime Time" of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 467, doi. 10.1007/s10557-020-07001-0
- By:
- Publication type:
- Article
Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 539, doi. 10.1007/s10557-020-07059-w
- By:
- Publication type:
- Article
Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 561, doi. 10.1007/s10557-020-07056-z
- By:
- Publication type:
- Article
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 491, doi. 10.1007/s10557-020-07050-5
- By:
- Publication type:
- Article
The Potential of Albuminuria as a Biomarker of Diabetic Complications.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 455, doi. 10.1007/s10557-020-07035-4
- By:
- Publication type:
- Article
TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 599, doi. 10.1007/s10557-020-06996-w
- By:
- Publication type:
- Article
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 549, doi. 10.1007/s10557-020-06988-w
- By:
- Publication type:
- Article
Major Cardiac–Psychiatric Drug–Drug Interactions: a Systematic Review of the Consistency of Drug Databases.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 3, p. 441, doi. 10.1007/s10557-020-06979-x
- By:
- Publication type:
- Article